Nivolumab,Relatlimab
BMS
['nivo', 'nsclc', 'sclc', 'relatlimab']
#asco23 abs#8500
surgical outcomes following nivo+/- relatlimab in ib-iiia #nsclc w/mpr 30%
presentation starts soon! 
Leslye M. Heisler Associate Professor of Lung Cancer Excellence @PennMedicine | AD @PC31 | Incoming Chair @ASCO #CCC | Tweets my own | COI: https://t.co/ghKU8KhBvl